SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
18498921
Source:
http://linkedlifedata.com/resource/pubmed/id/18498921
Search
Subject
(
58
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0019994
,
umls-concept:C0020933
,
umls-concept:C0035201
,
umls-concept:C0042153
,
umls-concept:C0087111
,
umls-concept:C0389169
,
umls-concept:C1701940
pubmed:issue
4
pubmed:dateCreated
2008-5-23
pubmed:abstractText
Ventilator-associated pneumonia (VAP) is a common nosocomial infection that is associated with prolonged length of stay (LOS) and significant mortality.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7706726
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Carbapenems
,
http://linkedlifedata.com/resource/pubmed/chemical/Imipenem
,
http://linkedlifedata.com/resource/pubmed/chemical/doripenem
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0149-2918
pubmed:author
pubmed-author:FriedlandIanI
,
pubmed-author:GastChrisC
,
pubmed-author:InghamMichaelM
,
pubmed-author:KetterNzeeraN
,
pubmed-author:LeeMichaelM
,
pubmed-author:MerchantSanjayS
,
pubmed-author:NathwaniDilipD
,
pubmed-author:QuintanaAlvaroA
pubmed:issnType
Print
pubmed:volume
30
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
717-33
pubmed:meshHeading
pubmed-meshheading:18498921-Anti-Bacterial Agents
,
pubmed-meshheading:18498921-Carbapenems
,
pubmed-meshheading:18498921-Costs and Cost Analysis
,
pubmed-meshheading:18498921-Dose-Response Relationship, Drug
,
pubmed-meshheading:18498921-Female
,
pubmed-meshheading:18498921-Follow-Up Studies
,
pubmed-meshheading:18498921-Hospital Costs
,
pubmed-meshheading:18498921-Humans
,
pubmed-meshheading:18498921-Imipenem
,
pubmed-meshheading:18498921-Infusions, Intravenous
,
pubmed-meshheading:18498921-Length of Stay
,
pubmed-meshheading:18498921-Male
,
pubmed-meshheading:18498921-Middle Aged
,
pubmed-meshheading:18498921-Pneumonia, Ventilator-Associated
,
pubmed-meshheading:18498921-Survival Rate
,
pubmed-meshheading:18498921-Treatment Outcome
pubmed:year
2008
pubmed:articleTitle
Hospital resource utilization with doripenem versus imipenem in the treatment of ventilator-associated pneumonia.
pubmed:affiliation
Johnson & Johnson Pharmaceutical Services, LLC, Raritan, New Jersey 08869-0602, USA. smercha5@psmus.jnj.com
pubmed:publicationType
Journal Article
,
Comparative Study
,
Randomized Controlled Trial
,
Multicenter Study
,
Clinical Trial, Phase III